We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNL icon
4001
Global Net Lease
GNL
$1.85B
$10K ﹤0.01%
812
-6,671
-89% -$82.7K
GOGO icon
4002
Gogo Inc
GOGO
$383M
$10K ﹤0.01%
665
-9,125
-93% -$132K
GTE icon
4003
Gran Tierra Energy
GTE
$325M
$10K ﹤0.01%
1,005
+495
+97% +$5.83K
GWRS icon
4004
Global Water Resources
GWRS
$247M
$10K ﹤0.01%
766
-4,898
-86% -$61.8K
HBB icon
4005
Hamilton Beach Brands
HBB
$448M
$10K ﹤0.01%
+813
New +$10.5K
HEPA
4006
DELISTED
Hepion Pharmaceuticals
HEPA
$10K ﹤0.01%
32
+12
+60% +$5.07K
HEWJ icon
4007
iShares Currency Hedged MSCI Japan ETF
HEWJ
$766M
$10K ﹤0.01%
391
+348
+809% +$12.3K
HMN icon
4008
Horace Mann Educators
HMN
$2.13B
$10K ﹤0.01%
270
-1,974
-88% -$74.4K
HNST icon
4009
The Honest Company
HNST
$519M
$10K ﹤0.01%
3,324
-11,308
-77% -$35.3K
HRTG icon
4010
Heritage Insurance Holdings
HRTG
$1.01B
$10K ﹤0.01%
5,485
+1,005
+22% +$1.66K
HSTM icon
4011
HealthStream
HSTM
$846M
$10K ﹤0.01%
406
-2,389
-85% -$57.3K
HTBK
4012
DELISTED
Heritage Commerce
HTBK
$10K ﹤0.01%
799
-15,277
-95% -$205K
IGMS
4013
DELISTED
IGM Biosciences
IGMS
$10K ﹤0.01%
598
-1,421
-70% -$28.4K
IMCG icon
4014
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.17B
$10K ﹤0.01%
184
-17,868
-99% -$963K
INDP icon
4015
Indaptus Therapeutics
INDP
$143M
$10K ﹤0.01%
241
+229
+1,908% +$11.6K
INMB icon
4016
INmune Bio
INMB
$60.2M
$10K ﹤0.01%
1,503
-2,406
-62% -$17.1K
INTA icon
4017
Intapp
INTA
$3.09B
$10K ﹤0.01%
381
-2,629
-87% -$58.1K
INTT icon
4018
inTEST
INTT
$179M
$10K ﹤0.01%
924
-603
-39% -$5.61K
INVA icon
4019
Innoviva
INVA
$1.53B
$10K ﹤0.01%
803
-23,576
-97% -$310K
ITOT icon
4020
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
$10K ﹤0.01%
122
-42
-26% -$3.58K
JELD icon
4021
JELD-WEN Holding
JELD
$167M
$10K ﹤0.01%
1,051
-11,969
-92% -$116K
KTTA icon
4022
Pasithea Therapeutics
KTTA
$16.1M
$10K ﹤0.01%
752
+469
+166% +$9.37K
LASR icon
4023
nLIGHT
LASR
$3.03B
$10K ﹤0.01%
1,013
-6,939
-87% -$71.6K
LIQT icon
4024
LiqTech
LIQT
$18.5M
$10K ﹤0.01%
3,172
+3
+0.1% +$10
LOCO icon
4025
El Pollo Loco
LOCO
$473M
$10K ﹤0.01%
966
-931
-49% -$9.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.